Effective September 1, 2026, Sever Pharma Solutions AB will become QPharma AB.
Malmö, Sweden, August 31, 2026
As part of our broader development, Sever Pharma Solutions AB is changing its name to QPharma AB, effective September 1, 2026, strengthening the visibility of an established and well-recognized name in Malmö. The organization, operations, ownership, and services remain unchanged, only the name changes back to its origin.
QPharma is an international pharmaceutical development and manufacturing partner, a CDMO specializing in polymer based complex drug delivery systems and high-potent processing. The QPharma name reflects a long-standing reputation for scientific expertise and trusted partnerships within the pharmaceutical industry and creates a unified platform as the company continues to expand internationally.
"QPharma is a name with a strong legacy, built over many years through the expertise and dedication of our people," says Fredrik Hultenius, CEO. "Operating under this name allows us to build on that foundation while strengthening our position as a leading partner in complex drug delivery."
QPharma's focus remains on helping customers navigate the growing complexity of advanced therapies, from early development through commercial supply.
About QPharma
QPharma is a pharmaceutical development and manufacturing partner specializing in complex drug delivery solutions, sterile injectables, solubility enhancement and high-potent pharmaceutical processing. Through scientific excellence, advanced technologies and trusted partnerships, QPharma helps customers develop, manufacture and bring advanced therapies to life, from early concepts to commercial supply.
For media inquiries, please contact:
Ulrike (Uli) Foley, Head of Global Business Development and Marketing
Email: ufoley@qpharma.com
For more information about QPharma AB, visit www.qpharma.com
